Telemedicine and Mobile Health Technology Are Effective in the Management of Digestive Diseases: A Systematic Review



Mobile applications and interactive websites are an increasingly used method of telemedicine, but their use lacks evidence in digestive diseases.


This study aims to explore digestive disease studies that use telemedicine to effectively manage disease activity, help monitor symptoms, improve compliance to the treatment protocol, increase patient satisfaction, and enhance the patient-to-provider communication.


EBSCO, PubMed, and Web of Science databases were searched using Medical Subject Headings and other keywords to identify studies that utilized telemedicine in patients with digestive disease. The PRISMA guidelines were used to identify 20 research articles that had data aligning with 4 common overlapping themes including, patient compliance (n = 13), patient satisfaction (n = 11), disease activity (n = 15), and quality of life (n = 13). The studies focused on digestive diseases including inflammatory bowel disease (n = 7), ulcerative colitis (n = 4), Crohn’s Disease (n = 1), irritable bowel syndrome (n = 6), and colorectal cancer (n = 2).


From the studies included in this systematic review, patient compliance and patient satisfaction ranged between 25.7–100% and 74–100%, respectively. Disease activity, measured by symptom severity scales and physiological biomarkers, showed improvements following telemedicine interventions in several, but not all, studies. Similar to disease activity, general and disease-specific quality of life showed improvements following telemedicine interventions in as little as 12 weeks in some studies.


Telemedicine and mobile health technology may be effective in managing disease activity and improving quality of life in digestive diseases. Future studies should explore both gastrointestinal and gastroesophageal diseases using these types of interventions.

This is a preview of subscription content, log in to check access.

Fig. 1
Fig. 2


  1. 1.

    Cross RK, Kane S. Integration of telemedicine into clinical gastroenterology and hepatology practice. Clin Gastroenterol Hepatol. 2017;15:175–181.

    Article  PubMed  Google Scholar 

  2. 2.

    Meyers DJ, Ozonoff A, Baruwal A, et al. Combining healthcare-based and participatory approaches to surveillance: trends in diarrheal and respiratory conditions collected by a mobile phone system by community health workers in rural Nepal. PLOS ONE. 2016;11:1–13.

    Article  CAS  Google Scholar 

  3. 3.

    Cross RK, Arora M, Finkelstein J. Acceptance of telemanagement is high in patients with inflammatory bowel disease. J Clin Gastroenterol. 2006;40:200–208.

    Article  PubMed  Google Scholar 

  4. 4.

    Larsen ME, Rowntree J, Young AM, et al. Chemotherapy side-effect management using mobile phones. Conference proceedings: annual international conference of the IEEE engineering in medicine and biology society. In: IEEE engineering in medicine and biology society. Annual conference. 2008;5152–5155.

  5. 5.

    Van Deen WK, van der Meulen-de Jong AE, Parekh NK, et al. Development and validation of an inflammatory bowel diseases monitoring index for use with mobile health technologies. Clin Gastroenterol Hepatol. 2016;14:1742–1750.

    Article  PubMed  Google Scholar 

  6. 6.

    Wu H, Chang C, Lin C, Tsai M, Chang C, Tseng M. Developing screening services for colorectal cancer on android smartphones. Telemed E-Health. 2014;20:687–695.

    Article  Google Scholar 

  7. 7.

    Pedersen N, Vegh Z, Burisch J, et al. Ehealth monitoring in irritable bowel syndrome patients treated with low fermentable oligo-, di-, mono-saccharides and polyols diet. World J Gastroenterol. 2014;20:6680–6684.

    Article  PubMed  PubMed Central  Google Scholar 

  8. 8.

    de Jong M, van der Meulen-de J, Romberg-Camps M, et al. Development and feasibility study of a telemedicine tool for all patients with IBD: MyIBDcoach. Inflamm Bowel Dis. 2017.

    PubMed Central  Article  PubMed  Google Scholar 

  9. 9.

    Pedersen N, Elkjaer M, Duricova D, et al. eHealth: individualisation of infliximab treatment and disease course via a self-managed web-based solution in Crohn’s disease. Aliment Pharmacol Ther. 2012;36:840–849.

    Article  PubMed  CAS  Google Scholar 

  10. 10.

    Chung C, Cook J, Bales E, Zia J, Munson SA. More than telemonitoring: health provider use and nonuse of life-log data in irritable bowel syndrome and weight management. J Med Internet Res. 2015.

    Article  PubMed  PubMed Central  Google Scholar 

  11. 11.

    Cross RK, Finkelstein J. Feasibility and acceptance of a home telemanagement system in patients with inflammatory bowel disease: a 6-month pilot study. Dig Dis Sci. 2007;52:357–364.

    Article  PubMed  Google Scholar 

  12. 12.

    Pedersen N, Thielsen P, Martinsen L, et al. eHealth: individualization of mesalazine treatment through a self-managed web-based solution in mild-to-moderate ulcerative colitis. Inflamm Bowel Dis. 2014;20:2276–2285.

    Article  PubMed  Google Scholar 

  13. 13.

    Elkjaer M, Shuhaibar M, Burisch J, et al. E-health empowers patients with ulcerative colitis: a randomised controlled trial of the web-guided ‘constant-care’ approach. Gut. 2010;59:1652–1661.

    Article  PubMed  Google Scholar 

  14. 14.

    Moher D, Liberati A, Tetzlaff J, Altman DG. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. J Clin Epidemiol. 2009;62:1006–1012.

    Article  PubMed  Google Scholar 

  15. 15.

    Sawares AS, Shen N, Xue Y, Abi-Jaoude A, Wiljer D. The impact of mobile apps on alcohol use disorder: a systematic review protocol. JMIR Res Protoc. 2017;6:e49.

    Article  PubMed  PubMed Central  Google Scholar 

  16. 16.

    Cross RK, Cheevers N, Finkelstein J. Home telemanagement for patients with ulcerative colitis (UC HAT). Dig Dis Sci. 2009;54:2463–2472.

    Article  PubMed  Google Scholar 

  17. 17.

    Cross RK, Cheevers N, Rustgi A, Langenberg P, Finkelstein J. Randomized, controlled trial of home telemanagement in patients with ulcerative colitis (UC HAT). Inflamm Bowel Dis. 2012;18:1018–1025.

    Article  PubMed  Google Scholar 

  18. 18.

    McCombie A, Gearry R, Andrews J, Mulder R, Mikocka-Walus A. Does computerized cognitive behavioral therapy help people with inflammatory bowel disease? A randomized controlled trial. Inflamm Bowel Dis J. 2016;22:171–181.

    Article  Google Scholar 

  19. 19.

    de Jong MJ, van der Meulen-de Jong AE, Romberg-Camps MJ, et al. Telemedicine for management of inflammatory bowel disease (myIBDcoach): a pragmatic, multicenter, randomised controlled trial. Lancet. 2017;390:959–968.

    Article  PubMed  Google Scholar 

  20. 20.

    Dorn SD, Palsson OS, Woldeghebriel M, et al. Development and pilot testing of an integrated, web-based self-management program for irritable bowel syndrome (IBS). Neurogastroenterol Motil. 2015;27:128–134.

    Article  PubMed  CAS  Google Scholar 

  21. 21.

    Everitt H, Moss-Morris R, Sibelli A, et al. Management of irritable bowel syndrome in primary care: the results of an exploratory randomised controlled trial of mebeverine, methylcellulose, placebo and a self-management website. BMC Gastroenterol. 2013;13:68. (Medline: 23602047).

    Article  PubMed  PubMed Central  Google Scholar 

  22. 22.

    Hunt MG, Moshier S, Milonova M. Brief cognitive-behavioral internet therapy for irritable bowel syndrome. Behav Res Ther. 2009;47:797–802. (Medline: 19570525).

    Article  PubMed  Google Scholar 

  23. 23.

    Ljótsson B, Andersson G, Andersson E, et al. Acceptability, effectiveness, and cost-effectiveness of internet-based exposure treatment for irritable bowel syndrome in a clinical sample: a randomized controlled trial. BMC Gastroenterol. 2011;11:110. (Medline: 21992655).

    Article  PubMed  PubMed Central  Google Scholar 

  24. 24.

    Ljótsson B, Hedman E, Lindfors P, et al. Long-term follow-up of internet-delivered exposure and mindfulness based treatment for irritable bowel syndrome. Behav Res Ther. 2011;49:58–61. (Medline: 21092934).

    Article  PubMed  Google Scholar 

  25. 25.

    Kearney N, McCann L, Norrie J, et al. Evaluation of a mobile phone-based, advanced symptom management system (ASyMS) in the management of chemotherapy-related toxicity. Supportive Care Cancer. 2009;17:437–444.

    Article  CAS  Google Scholar 

  26. 26.

    Tonkin-Crine S, Bishop FL, Ellis M, Moss-Morris R, Everitt H. Exploring patients’ views of a cognitive behavioral therapy-based website for the self-management of irritable bowel syndrome symptoms. J Med Internet Res. 2013.

    PubMed  PubMed Central  Article  Google Scholar 

  27. 27.

    Aguas M, Del Hoyo J, Faubel R, Nos P. Use of telemedicine in inflammatory bowel disease: a real monitoring option? Expert Rev Gastroenterol Hepatol. 2016;10:879–881.

    PubMed  CAS  Article  Google Scholar 

  28. 28.

    Hommel KA, Gray WN, Hente E, et al. The telehealth enhancement of adherence to medication (TEAM) in pediatric IBD trial: design and methodology. Contemp Clin Trials. 2015;43:105–113.

    Article  PubMed  PubMed Central  Google Scholar 

  29. 29.

    Cross RK, Jambaulikar G, Langenberg P, et al. TELEmedicine for patients with inflammatory bowel disease (TELE-IBD): design and implementation of randomized clinical trial. Contemp Clin Trials. 2015;42:132–144.

    Article  PubMed  Google Scholar 

  30. 30.

    Castro HK, Cross RK, Finkelstein J. Using a home automated telemanagement (HAT) system: Experiences and perceptions of patients with inflammatory bowel disease. In: AMIA Annual Symposium Proceedings. 2006;872.

  31. 31.

    Cross RK, Finkelstein J. Challenges in the design of a home telemanagement trial for patients with ulcerative colitis. Clin Trials. 2009;6:649–657.

    Article  PubMed  Google Scholar 

  32. 32.

    Hommel KA, Hente E, Herzer M, Ingerski LM, Denson LA. Telehealth behavioral treatment for medication nonadherence: a pilot and feasibility study. Eur J Gastroenterol Hepatol. 2013;25:469–473.

    Article  PubMed  PubMed Central  Google Scholar 

  33. 33.

    Thomson M, Volk M, Kim H, Piette J, Kim HM, Piette JD. An automated telephone monitoring system to identify patients with cirrhosis at risk of re-hospitalization. Dig Dis Sci. 2015;60:3563–3569.

    Article  PubMed  Google Scholar 

  34. 34.

    Sharma S, Ward EC, Burns C, Theodoros D, Russell T. Assessing swallowing disorders online: a pilot telerehabilitation study. Telemed J E-Health. 2011;17:688–695.

    Article  PubMed  Google Scholar 

  35. 35.

    Krier M, Kaltenbach T, McQuaid K, Soetikno R. Potential use of telemedicine to provide outpatient care for inflammatory bowel disease. Am J Gastroenterol. 2011;106:2063–2067.

    Article  PubMed  Google Scholar 

  36. 36.

    Heida A, Knol M, Kobold AM, Bootsman J, Dijkstra G, van Rheenen PF. Agreement between home-based measurement of stool calprotectin and ELISA results for monitoring inflammatory bowel disease activity. Clin Gastroenterol Hepatol. 2017.

    PubMed  Article  Google Scholar 

Download references


The author has not received payment or services from a third party for any aspect of the submitted work at any time. The authors’ employer has not received payment or services from a third party for any aspect of the submitted work at any time. There are no other relationships or activities that readers could perceive to have influenced, or that give the appearance of potentially influencing, what is written in the submitted work.

Author information



Corresponding author

Correspondence to Brian C. Helsel.

Ethics declarations

Conflict of interest

The author has no conflicts of interest to report.

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Helsel, B.C., Williams, J.E., Lawson, K. et al. Telemedicine and Mobile Health Technology Are Effective in the Management of Digestive Diseases: A Systematic Review. Dig Dis Sci 63, 1392–1408 (2018).

Download citation


  • Telemedicine
  • Systematic review
  • Gastrointestinal diseases
  • Digestive system diseases